WuXi Biologics (Cayman) Inc.

BMV:2269 N Stock Report

Market Cap: Mex$132.7b

WuXi Biologics (Cayman) Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BMV:2269 N Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Nov 24SellMex$3,507,520Weichang ZhouIndividual91,490Mex$38.34
20 Nov 24SellMex$11,396,199Zhisheng ChenIndividual297,258Mex$38.34
24 Jun 24BuyMex$38,627,410Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany1,445,000Mex$26.73
21 Jun 24BuyMex$27,192,473Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany1,000,000Mex$27.19
20 Jun 24BuyMex$5,625,185Ge Li And Ning Zhao Family Foundation, Endowment ArmCompany200,000Mex$28.13
12 Jun 24SellMex$2,642,343Weichang ZhouIndividual95,919Mex$27.55
12 Jun 24SellMex$15,983,394Zhisheng ChenIndividual580,209Mex$27.55
16 May 24SellMex$1,373,919,990JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany44,283,850Mex$31.03
13 May 24BuyMex$1,064,985,019JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany34,381,199Mex$30.98
28 Mar 24BuyMex$24,508,154Wuxi Biologics Holdings LimitedCompany831,000Mex$29.49
27 Mar 24BuyMex$7,139JP Morgan Asset ManagementCompany247Mex$28.90
27 Mar 24BuyMex$476,882JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany16,500Mex$28.90
27 Mar 24BuyMex$98,314,742JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,401,667Mex$28.90
27 Mar 24SellMex$257,140JP Morgan Asset ManagementCompany8,897Mex$28.90
27 Mar 24SellMex$101,157JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,500Mex$28.90
26 Mar 24SellMex$158,892,107JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,465,114Mex$29.07
19 Mar 24SellMex$530,525,969JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany17,602,783Mex$30.14
15 Mar 24BuyMex$690,645,021JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany21,989,717Mex$31.41
08 Mar 24BuyMex$31,348,213JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany831,114Mex$37.72
08 Mar 24SellMex$736,752JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany19,533Mex$37.72
08 Mar 24SellMex$217,276,984JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,760,518Mex$37.72
06 Mar 24SellMex$540,845,661JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany11,851,005Mex$45.64
04 Mar 24BuyMex$5,626J.P. Morgan Private Wealth Advisors LLCCompany126Mex$44.65
04 Mar 24BuyMex$625,142JP Morgan Asset ManagementCompany14,000Mex$44.65
04 Mar 24BuyMex$1,205,631JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany27,000Mex$44.65
04 Mar 24BuyMex$787,241,299JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany17,630,196Mex$44.65
04 Mar 24SellMex$647,469JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany14,500Mex$44.65
01 Mar 24SellMex$169,009,263JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany4,124,046Mex$40.98
28 Feb 24BuyMex$228,569,185JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,541,524Mex$41.25
26 Feb 24SellMex$770,558,157JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany18,636,736Mex$41.35

Insider Trading Volume

Insider Buying: 2269 N insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2269 N?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders13,690,9600.328%
Private Companies584,191,13314%
General Public1,704,514,49640.8%
Institutions1,873,499,47744.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 47.09% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14%
Wuxi Biologics Holdings Limited
584,191,133Mex$18.6b0%no data
5.18%
BlackRock, Inc.
216,256,117Mex$6.9b4.12%0.01%
4.97%
Capital Research and Management Company
207,744,787Mex$6.6b0%0.02%
3.41%
The Vanguard Group, Inc.
142,408,937Mex$4.5b0.33%no data
3.02%
E Fund Management Co., Ltd.
126,236,990Mex$4.0b0.01%0.35%
2.3%
Baillie Gifford & Co.
95,932,929Mex$3.0b7.32%0.08%
1.91%
JP Morgan Asset Management
79,949,986Mex$2.5b-20.2%0.02%
1.68%
Norges Bank Investment Management
70,219,981Mex$2.2b12%0.01%
1.32%
State Street Global Advisors, Inc.
54,959,858Mex$1.7b-0.92%no data
0.79%
FMR LLC
33,143,132Mex$1.1b-34.4%no data
0.77%
JPMorgan Chase & Co, Brokerage and Securities Investments
31,991,346Mex$1.0b355%0.05%
0.75%
Invesco Great Wall Fund Management Co. Ltd
31,321,635Mex$995.1m0%0.29%
0.75%
Schroder Investment Management (Hong Kong) Ltd.
31,211,500Mex$991.6m0.09%0.31%
0.74%
Bosera Asset Management Co., Ltd.
31,075,500Mex$987.3m0%0.31%
0.69%
Zhong Ou Fund Management Co., Ltd
28,605,169Mex$908.8m0%0.2%
0.65%
Bank of Communications Schroder Fund Management Co., Ltd.
27,143,955Mex$862.4m0%0.34%
0.6%
UBS Asset Management AG
25,223,414Mex$801.4m0.99%0.01%
0.59%
Franklin Resources, Inc.
24,464,350Mex$777.3m1.44%0.02%
0.57%
abrdn plc
23,972,518Mex$761.6m0%0.03%
0.52%
AEGON-Industrial Fund Management Co. Ltd.
21,821,254Mex$693.3m0%0.24%
0.41%
Harvest Fund Management Co. Ltd.
17,170,195Mex$545.5m0%0.1%
0.41%
Schroder Investment Management (Singapore) Ltd.
17,000,000Mex$540.1m0%0.19%
0.39%
Geode Capital Management, LLC
16,450,810Mex$522.7m1.71%no data
0.34%
China Asset Management Co. Ltd.
14,144,263Mex$449.4m10.9%0.04%
0.33%
Hongde Fund Management Co., Ltd.
13,966,149Mex$443.7m0%0.56%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/03/18 08:24
End of Day Share Price 2023/12/20 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

WuXi Biologics (Cayman) Inc. is covered by 56 analysts. 32 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wai Chak YuenBOCI Research Ltd.
Linda LuBOCI Research Ltd.
Bo LiBofA Global Research